πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12180277

LILRB4-binding antibody and methods of use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12178787

T cell receptors for immunotherapy

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12180251

Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for tre

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12181555

3-dimensional representations of post-contrast enhanced brain lesions

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12178848

Methods and compositions for the treatment of exocrine pancreatic insufficiency

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12178417

Devices and methods for umbilical cord processing

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12178868

Immunogenic compositions and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12179037

Radiotherapies and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12173061

Compositions and methods for treatment of chronic lung diseases

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12173317

Use of histone modifiers to reprogram effector T cells

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12173084

Phosphorylated dicer antibody and methods of use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12171803

Methods of CD40 and toll like receptor immune activation

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12173089

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12168691

VHS format bi-specific antibodies specific for HER2 and VEGF and use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12168678

Heme sequesting peptides and uses therefor

The Board of Regents of the University of Texas System Β· Granted Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12163168

Engineered primate cystine/cysteine degrading enzymes for therapeutic uses

The Board of Regents of the University of Texas System Β· Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12162937

Methods of treating an inflammatory disorder by administering an antibody which binds to a

The Board of Regents of the University of Texas System Β· Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12161618

Methods of identifying and treating patients with HIF-2 inhibitor resistance

The Board of Regents of the University of Texas System Β· Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12151062

Compositions and devices to administer pharmaceutical compositions nasally

The Board of Regents of the University of Texas System Β· Granted Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12152071

EGFL6 specific monoclonal antibodies and methods of their use

The Board of Regents of the University of Texas System Β· Granted Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12144828

Human Kynureninase enzymes and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12133924

Compositions and methods for organ specific delivery of nucleic acids

The Board of Regents of the University of Texas System Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12134648

Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor

The Board of Regents of the University of Texas System Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12134609

Quinoline cGAS antagonist compounds

The Board of Regents of the University of Texas System Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted